Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?

被引:0
|
作者
Pinthus, Jehonathan H. [1 ]
Duivenvoorden, Wilhelmina C. [1 ]
机构
[1] McMaster Univ, Div Urol, Dept Surg, Hamilton, ON, Canada
来源
关键词
VENOUS THROMBOEMBOLISM;
D O I
10.5489/cuaj.4394
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:39 / 40
页数:2
相关论文
共 50 条
  • [41] Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer
    Chow, Alexander K.
    Vourganti, Srinivas
    Konety, Badrinath R.
    EUROPEAN UROLOGY, 2021, 80 (03) : 386 - 386
  • [42] Immediate versus deferred androgen-deprivation therapy for localized prostate cancer
    Nature Clinical Practice Urology, 2006, 3 (7): : 348 - 349
  • [43] Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
    Cattrini, Carlo
    Zanardi, Elisa
    Boccardo, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) : 2350 - +
  • [44] Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Roe, Kathrine
    Mikalsen, Lars T. G.
    van der Kogel, Albert J.
    Bussink, Johan
    Lyng, Heidi
    Ree, Anne H.
    Marignol, Laure
    Olsen, Dag R.
    RADIATION ONCOLOGY, 2012, 7
  • [45] Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives
    Pinto, F.
    Calarco, A.
    Totaro, A.
    Sacco, E.
    Volpe, A.
    Racioppi, M.
    D'Addessi, A.
    Bassi, P. F.
    UROLOGIA JOURNAL, 2010, 77 (02) : 71 - 83
  • [46] Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Kathrine Røe
    Lars TG Mikalsen
    Albert J van der Kogel
    Johan Bussink
    Heidi Lyng
    Anne H Ree
    Laure Marignol
    Dag R Olsen
    Radiation Oncology, 7
  • [47] Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
    Wolff, Johannes M.
    Abrahamsson, Per-Anders
    Irani, Jacques
    da Silva, Fernando Calais
    BJU INTERNATIONAL, 2014, 114 (04) : 476 - 483
  • [48] Feasibility of androgen-deprivation and radiation therapy with docetaxel for localized high-risk prostate cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Mizokami, Atsushi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (07) : 1324 - 1326
  • [49] Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer
    Angela S. Alberga
    Roanne J. Segal
    Robert D. Reid
    Chris G. Scott
    Ronald J. Sigal
    Farah Khandwala
    James Jaffey
    George A. Wells
    Glen P. Kenny
    Supportive Care in Cancer, 2012, 20 : 971 - 981
  • [50] Personalizing the Duration of Androgen-Deprivation Therapy Use in the Management of Intermediate-Risk Prostate Cancer
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (04) : 301 - U151